Clinical trial · Observational
Aggressive Spinal Hemangioma
Management Of Aggressive Spinal Hemangioma
NCT06996873CI-TRIAL-00090360not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research is a case series analysis to evaluate aggressive vertebral hemangiomas. It focuses on clinical presentation, diagnostic imaging accuracy (X-ray, MRI, MSCT, angiography), and treatment efficacy. The primary goal is to establish optimal management protocols.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Aggressive Spinal Hemangiomas | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Patients with symptomatic, radiologically confirmed aggressive spinal hemangiomas treated at Assiut
- description
- Confirmed diagnosis of aggressive vertebral hemangioma via imaging (MRI/MSCT) and clinical symptoms (e.g., pain, neurological deficits).
Primary outcomes (1)
- measure
- Neurological Symptom Resolution
- timeFrame
- 3 months
- description
- using the Pain intensity (VAS scale)
Secondary outcomes (1)
- measure
- Functional Status Improvement
- timeFrame
- 3 months
- description
- using ASIA Impairment Scale (primary) Threshold: ≥1-grade improvement on ASIA scale sustained for ≥3 months
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients diagnosed with aggressive spinal hemangiomas based on clinical symptoms and imaging findings. * Cases confirmed through diagnostic modalities such as X-ray, MRI, MSCT, or angiography. * Patients presenting with symptoms such as pain, neurological deficits, or spinal instability attributable to the hemangioma. Exclusion Criteria: * Patients with incidentally discovered spinal hemangiomas (asymptomatic cases found during evaluations for unrelated conditions). * Cases lacking sufficient diagnostic evidence to confirm aggressive spinal hemangioma.
References
Publications (0)
Data not yet available
No reference posted for this study.